Tammy M. Havener - Concepedia

Author

Tammy M. Havener

University of North Carolina at Chapel Hill ORCID

Also Known As

Everitt, Lorraine, Hardison, Nicholas E, Havener, Tammy, Havener, Tammy M., Jack, John, Marvel, Skylar W., Medina, Marisa W, Motsinger-Reif, Alison A., Quintanhila, Julia, Quintanilha, Julia C. F.

Publications

491

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill North Carolina State University Moffitt Cancer Center Duke University Goethe University Frankfurt

About

Tammy M. Havener is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	71
2	Cell Biology	2	2	59
3	Engineering	1	1	12
4	Cellular Physiology	1	1	18
5	Molecular Biology	1	1	18

Tammy M. Havener

Publications

419

Citations

H-Index

Page 1

	Year	Citations
Genetic Variants in <i>CPA6</i> and <i>PRPF31</i> Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes Daniel M. Rotroff, Sook Wah Yee, Kaixin Zhou, Diabetes	2018	54
Pharmacogenomic Characterization of US FDA-approved Cytotoxic Drugs Eric Peters, Alison A. Motsinger‐Reif, Tammy M. Havener, Pharmacogenomics	2011	46
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma Christopher R. M. Asquith, Kaleb M. Naegeli, Michael P. East, Journal of Medicinal Chemistry Tumor BiologyGak InhibitionMedicineReceptor Tyrosine KinasePharmacology	2019	41
Synergistic drug combinations and machine learning for drug repurposing in chordoma Edward Anderson, Tammy M. Havener, Kimberley M. Zorn, Scientific Reports	2020	41
Genetic Variants in <i>HSD17B3</i>, <i>SMAD3</i>, and <i>IPO11</i> Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes Daniel M. Rotroff, Sonja S. Pijut, Skylar W. Marvel, Clinical Pharmacology & Therapeutics	2017	37
A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT Chad Brown, Tammy M. Havener, Marisa W. Medina, Pharmacogenetics and Genomics	2012	32
Genome-Wide Association and Pharmacological Profiling of 29 Anticancer Agents Using Lymphoblastoid Cell Lines Chad Brown, Tammy M. Havener, Marisa W. Medina, Pharmacogenomics	2014	30
Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trial Skylar W. Marvel, Daniel M. Rotroff, Michael J. Wagner, PeerJ	2017	21
Multivariate methods and software for association mapping in dose‐response genome‐wide association studies Chad Brown, Tammy M. Havener, Marisa W. Medina, BioData Mining	2012	19
Multi-omic profiling reveals the ataxia protein sacsin is required for integrin trafficking and synaptic organization Lisa E. L. Romano, Wen Yih Aw, Kathryn Hixson, Cell Reports Integrin TraffickingMolecular BiologyProtein SacsinCytoskeletonCellular Neurobiology	2022	18

Page 1